The size of the Global Clostridium Botulinum Market is expected to grow at an impressive CAGR in the coming next 5 years timespan.
Botulism is a disease which causes paralysis and is caused by the bacteria Clostridium botulinum. Some symptoms include weakness, paralysis, vision and swallowing, breathing and speaking problems. The weakness further leads to fatigue of limb muscles. The symptoms are not caused by the bacterium itself, but by the toxin produced by the bacterium.
The major factors that drives growth of botulism market includes, lack of cleanliness in certain regions of the world and increase in the awareness about disease and treatments, increase in R&D practices and availability of efficient solutions for botulism. In addition, owing to strong efforts by WHO and CDC, the disease is getting irradiated slowly.
However, high cost of research and development projects and government austerity are some of the hurdles expected to hinder the growth of botulism market.
REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2019 to 2025 |
Base Year |
2019 |
Forecast Period |
2020 to 2025 |
Segments Covered |
By Product Type, Application, End User and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
This research report on the Global Clostridium Botulinum Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2025.
Clostridium Botulinum Market – By Product Type:
Clostridium Botulinum Market – By Application:
On the basis of application, the aesthetic segment accounted for a major share of the market.
Clostridium Botulinum Market – By Distribution Channel:
Clostridium Botulinum Market – By Region:
The Clostridium Botulinum market was dominated by North America followed by Europe. Asia Pacific is considered to be a lucrative market is expected to grow at a high CAGR.
TOP COMPANIES IN THE MARKET
List of top companies dominating the Global Clostridium Botulinum Market profiled in this report are XOMA Ltd., AlphaVax, Inc., Cangene Corporation, Morphotek, Inc., DynPort Vaccine Company LLC, Emergent BioSolutions, Inc., Molecular Targeting Technologies, Inc. and many others.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Botulinum toxin type A
5.1.3 Botulinum toxin type B
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Aesthetic
5.2.3 Therapeutics
5.2.4 Y-o-Y Growth Analysis, By application
5.2.5 Market Attractiveness Analysis, By application
5.2.6 Market Share Analysis, By application
5.3 Distribution channel
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Clinics
5.3.4 Retail pharmacies
5.3.5 Y-o-Y Growth Analysis, By distribution channel
5.3.6 Market Attractiveness Analysis, By distribution channel
5.3.7 Market Share Analysis, By distribution channel
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By application
6.1.3.4 By distribution channel
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By application
6.1.4.4 By distribution channel
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By application
6.1.5.4 By distribution channel
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 DynPort Vaccine Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Emergent BioSolutions, Inc.
8.3 XOMA Ltd.
8.4 AlphaVax
8.5 Cangene Corporation
8.6 Morphotek, Inc.
8.7 Morphotek, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports